» Articles » PMID: 40065236

Impact of Hypotonic Hyponatremia on Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement: a National Inpatient Sample

Overview
Publisher Biomed Central
Date 2025 Mar 11
PMID 40065236
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Transcatheter aortic valve replacement (TAVR) has emerged as a major therapeutic option for treating aortic stenosis. Hyponatremia is a common electrolyte disorder closely associated with adverse cardiovascular outcomes. However, large-scale studies investigating the impact of hypotonic hyponatremia on outcomes among TAVR patients are lacking.

Methods: We queried patients who underwent TAVR with concomitant hypo-osmolar hyponatremia (defined as a serum sodium concentration < 135 mEq/L with a serum osmolality < 280 mOsm/kg) using the National Inpatient Sample (2016-2021). Multivariate regression analysis and 1:1 propensity score matching (PSM) were performed to assess the associations between hypo-osmolar hyponatremia and in-hospital mortality and major adverse events (including acute kidney injury [AKI], acute myocardial infarction [AMI], and cardiogenic shock [CS]). Furthermore, sensitivity analysis was performed to assess the robustness of the findings.

Results: Among the total weighted national estimate of 370,680 patients who underwent TAVR, 13,865 (3.7%) had concomitant hypo-osmolar hyponatremia. These patients had a significantly increased risk of in-hospital mortality (aOR: 1.37; 95% CI: 1.08-1.74) and a greater likelihood of developing AKI (aOR: 3.39; 95% CI: 3.07-3.74), AMI (aOR: 3.20; 95% CI: 2.77-3.70), and CS (aOR: 2.96; 95% CI: 2.52-3.47). After PSM and sensitivity analysis, these associations remained significant.

Conclusion: In TAVR patients, hypo-osmolar hyponatremia is associated with increased in-hospital mortality and adverse events, including AKI, AMI, and CS.

References
1.
Breen T, Brueske B, Sidhu M, Murphree D, Kashani K, Barsness G . Abnormal Serum Sodium is Associated With Increased Mortality Among Unselected Cardiac Intensive Care Unit Patients. J Am Heart Assoc. 2020; 9(2):e014140. PMC: 7033827. DOI: 10.1161/JAHA.119.014140. View

2.
Sica D . Hyponatremia and heart failure--pathophysiology and implications. Congest Heart Fail. 2005; 11(5):274-7. DOI: 10.1111/j.1527-5299.2005.04180.x. View

3.
Gheorghiade M, Abraham W, Albert N, Stough W, Greenberg B, OConnor C . Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry. Eur Heart J. 2007; 28(8):980-8. DOI: 10.1093/eurheartj/ehl542. View

4.
Hasking G, Esler M, Jennings G, Burton D, Johns J, Korner P . Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation. 1986; 73(4):615-21. DOI: 10.1161/01.cir.73.4.615. View

5.
Barbanti M, Webb J, Gilard M, Capodanno D, Tamburino C . Transcatheter aortic valve implantation in 2017: state of the art. EuroIntervention. 2017; 13(AA):AA11-AA21. DOI: 10.4244/EIJ-D-17-00567. View